Astellas Pharma, Inc. (ALPMY)
14.22
-0.20
(-1.39%)
USD |
OTCM |
Jan 13, 16:00
Astellas Pharma Price: 14.22 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 25.15 |
| Takeda Pharmaceutical Co., Ltd. | 16.01 |
| Nxera Pharma Co., Ltd. | 5.71 |
| PeptiDream Inc. | 11.00 |
| Stemcell Holdings, Inc. | 0.06 |
Price Related Metrics
| PE Ratio | 29.72 |
| PS Ratio | 1.895 |
| PEG Ratio | 0.2094 |
| Price to Book Value | 2.333 |
| Price to Free Cash Flow | 11.03 |
| Earnings Yield | 3.36% |
| Market Cap | 25.47B |
| PEGY Ratio | 0.2094 |
| Operating PE Ratio | 10.55 |
| Normalized PE Ratio | 29.72 |